NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.

We have included the web address to online sources used in developing and reviewing this article for documentation purposes only. Links included on this Sources page are valid, working links at the time they are posted. Please be aware that the source owner may, from time to time, reorganize the source web site, which can result in broken links on our pages. If you wish to access a source and come across a broken link, you may still be able to access it by entering just the parent web address in your browser's address bar (eg, "www.nih.gov") and then by entering the source title in the site's search feature.

S2
Clinical Chemistry: Principles, Procedures, and Correlations. Bishop M, Duben-Engelkirk J, Fody E, eds. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2000.

S3
Sacher RA, McPherson RA, Campos J. Widmann’s Clinical Interpretation of Laboratory Tests. 11th ed. Philadelphia: F.A. Davis Company; 2000.

S4
Goodman & Gilman's The Pharmacological Basis Of Therapeutics. 11th Edition. Lazo J, Goodman L S, Parker K L, eds, McGraw-Hill, September 2005.

S5
National Heart, Lung, and Blood Institute, (September 2003). Heart and Vascular Diseases: Heart Failure: Summary page (On line information). Available at: http://www.nhlbi.nih.gov/health/dci/Diseases/Hf/HF_All.html

S6
Terra, S G, Washam J B, Dunham, G D, and Gattis W A, (Oct 1999). Therapeutic Range of Digoxin’s Efficacy in Heart Failure: What Is the Evidence? Pharmacotherapy, 19(10):1123-1126, (On line journal). Available at: http://www.medscape.com/viewarticle/418044

S7
Gibbs C R, Davies M K Davies, Lip G Y H, (Feb 2000). Management: Digoxin and other inotropes, Beta-blockers, and antiarrhythmic and antithrombotic treatment, BMJ. 320(7233): 495–498. (PDF file). Availalbe at: http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1127534

S8
Mihai Gheorghiade, MD; Kirkwood F. Adams, Jr, MD; Wilson S. Colucci, MD (2004). Digoxin in the Management of Cardiovascular Disorders, Circulation; 109:2959-2964 (On line journal). Available online

S9
Rich, M. (2003 September). Drug Therapy of Heart Failure in the Elderly. Am J Geriatr Cardiol 12(4):235-242 (On line journal). Available at: http://www.medscape.com/viewarticle/460844

S10
Yusuf, S (November 1997). Digoxin in heart failure: results of the recent digoxin investigation group trial in the context of other treatments for heart failure Eur Heart J, 18: 1685-1688. (PDF file). Available online

S11
The Digitalis Investigation Group, (February 1997). The Effect Of Digoxin on Mortality and Morbidity in Patients with Heart Failure, NEJM volume 336:525-533 (On line journal). Available online: http://content.nejm.org/cgi/content/full/336/8/525

S12
Catherine A. Hammett-Stabler, PhD, DABCC, FACB. Pathology and Laboratory Medicine, UNC-Chapel Hill.